APA (7th ed.) Citation

Hardy, J., Haywood, A., Gogna, G., Martin, J., Yates, P., Greer, R., & Good, P. (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Current controlled trials in cardiovascular medicine, 21(1), 611-8. https://doi.org/10.1186/s13063-020-04541-6

Chicago Style (17th ed.) Citation

Hardy, Janet, Alison Haywood, Gauri Gogna, Jennifer Martin, Patsy Yates, Ristan Greer, and Phillip Good. "Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: A Double-blind, Placebo-controlled, Randomised Clinical Trial of Efficacy and Safety of 1:1 Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 611-8. https://doi.org/10.1186/s13063-020-04541-6.

MLA (9th ed.) Citation

Hardy, Janet, et al. "Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: A Double-blind, Placebo-controlled, Randomised Clinical Trial of Efficacy and Safety of 1:1 Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 611-8, https://doi.org/10.1186/s13063-020-04541-6.